BARCLAYS PLC - TALARIS THERAPEUTICS INC ownership

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of TALARIS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$50
+138.1%
17,696
+151.0%
0.00%
Q2 2023$21
-40.0%
7,049
-62.4%
0.00%
Q1 2023$35
+169.2%
18,760
+41.7%
0.00%
Q4 2022$13
-99.9%
13,242
+65.0%
0.00%
Q3 2022$22,000
-40.5%
8,027
-1.8%
0.00%
Q2 2022$37,000
-67.5%
8,174
-29.4%
0.00%
Q1 2022$114,00011,5800.00%
Other shareholders
TALARIS THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Qiming U.S. Ventures Management, LLC 2,932,606$8,240,62310.94%
BML Capital Management, LLC 2,000,000$5,620,0005.16%
Nantahala Capital Management 2,953,129$8,298,2920.71%
GREAT POINT PARTNERS LLC 1,000,000$2,810,0000.51%
Acuitas Investments, LLC 194,547$546,6770.32%
Affinity Asset Advisors, LLC 400,000$1,124,0000.32%
RA Capital Management 2,403,238$6,753,0990.13%
Artal Group S.A. 914,262$2,5690.11%
Blackstone Inc. 8,089,315$22,730,9750.10%
QVT Financial LP 589,314$1,655,9720.09%
View complete list of TALARIS THERAPEUTICS INC shareholders